Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors

Molecular Pharmacology

Volumn 53, Issue 2, 1998, Pages 262-269

  Biessen, Erik A L ^a,b   Vietsch, Helene ^a   Kuiper, Johan ^a   Bijsterbosch, Martin K ^a   Van Berkel, Theo J C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENYL PHOSPHATE; ADENOSINE DERIVATIVE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CHLOROQUINE; EDETIC ACID; FUCOIDIN; GUANOSINE PHOSPHATE; HEPARIN; LEVAMISOLE; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MONENSIN; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGODEOXYNUCLEOTIDE PHOSPHODIESTER; PHOSPHORUS 32; POLYADENYLIC ACID; POLYANION; POLYCYTIDYLIC ACID; POLYGUANYLIC ACID; POLYINOSINIC ACID; SCAVENGER RECEPTOR; SINGLE STRANDED DNA; SODIUM AZIDE; SUCROSE; TARTARIC ACID; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG UPTAKE; ENDOTHELIUM CELL; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER CELL; LIVER CLEARANCE; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031909123     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.2.262     Document Type: Article

References (37)

1. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, and Krieger M (1993) Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J Lipid Res 34:983-1000.
2. Benimetskaya L, Loike JD, Khaled Z, Loike G, Silverstein SC, Cao L, El Khoury J, Cai TQ, and Stein CA (1997) Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nat Med 3:414-420.
3. Bennet RM, Gabor GT, and Merritt MM (1985) DNA binding to leukocytes. J Clin Invest 76:2182-2190.
4. Biessen EAL, Bakkeren HF, Beuting DM, Kuiper J, and Van Berkel ThJC (1994) Recognition of both fucose- and galactose-exposing particles by the hepatic fucose receptor depends on the particle size. Biochem J 299:291-296.
5. Biessen EAL, Norder JA. Horn AS, and Robillard GT (1988) Evidence for the existence of at least two different binding sites for 5-HT-reuptake inhibitors within the 5-HT-reuptake system from human blood platelets. Biochem Pharm 37:3959-3966.
6. Bijsterbosch MK, Ziere GJ, and Van Berkel ThJC (1989) Lactosylated low-density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol Pharmacol 36:484-489.
7. Caster WO, Simon AB, and Armstrong WD (1955) Evans blue space in tissues of the rat. Am J Physiol 183:317-321.
8. Crooke ST and Bennet CF (1996) Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol 36:107-129.
9. De Rijke YB, Biessen EAL, Vogelezang CJM, and Van Berkel ThJC (1994) Binding characteristics of scavenger receptors on liver endothelial and Kupffer cells for modified low-density lipoproteins. Biochem J 304:69-73.
10. De Smidt PC, Le Doan T, De Falko S, and Van Berkel ThJC (1991) Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acid Res 19:4695-4700.
11. Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, Yazaki Y, Matsumoto A, and Kodama T (1993) Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem 268:2126-2133.
12. Emlen W, Rifai A, Magilavy D, and Mannik M (1988) Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells. Am J Pathol 133:54-60.
13. Endeman G, Stanton LW, Madden KS, Bryant CM, White RT, and Protter AA (1993) CD36 is a receptors for oxidized low density lipoprotein. J Biol Chem 268:11811-11816.
14. Hampton RY, Golenbak DT, Penman M, Krieger M, and Raetz CR (1991) Recognition and plasma clearance of endotoxin by scavenger receptors. Nature (Lond) 353:342-344.
15. Horiuchi S, Takata K, Maeda H, and Morino Y (1985) Scavenger receptor function of sinusoidal liver cells: acetylated low-density-lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin. J Biol Chem 259:53-56.
16. Inagaki M, Togawa K, Carr BI, Ghosh K, and Cohen JS (1994) Antisense oligonucleotides: inhibition of liver cell proliferation and in vivo disposition. Transplant Proc 24:2971-2972.
17. Kuiper J, Bakkeren HF, Biessen EAL, and Van Berkel ThJC (1994) Characterisation of the interaction of galactose-exposing particles with rat Kupffer cells. Biochem J 299:285-290.
18. Loke S, Stein C, and Zhang X (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86:3474-3478.
19. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
20. Nagelkerke JF, Barto KP, and Van Berkel ThJC (1983) In vivo and in vitro uptake and degradation of acetylated LDL by rat liver endothelial, Kupffer and parenchymal cells. J Biol Chem 258:12221-12227.
21. Pearson AM, Rich A, and Krieger M (1993) Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J Biol Chem 268:3546-3554.
22. Redgrave TG, Roberts DCK, and West CE (1975) Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65:42-49.
23. Rifai A, Brysch W, Fadden K, Clark J, and Slingensiepen KH (1996) Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice. Am J Pathol 149:717-725.
24. Sambrook J, Frits EF, and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd ed, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. 3H-labeled oligonucleotides. Mol Pharmacol 45:932-943.
26. Sawai K, Mahato RI, Oka Y, Takakura Y, and Hashida M (1996) Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake. J Pharmacol Exp Ther 279:284-290.
27. Stanton LW, White RT, Bryant CM, Protter AA, and Endemann G (1992) A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoproteins. J Biol Chem 267:22446-22451.
28. Stein CA and Cheng YC (1993) Antisense oligonucleotides as therapeutic agents: is the bullet really magical? Science (Washington DC) 261:1004-1011.
29. Stein CA, Tonkinson JL, Zhang LM, Yabukov L, Gervasoni J, Taub R, and Rotenberg SA (1993) Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32:4855-4861.
30. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi K, Takahashi K, Kruijt JK, Van Berkel ThJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, and Kodama T (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (Lond) 386:292-296.
31. Van Berkel ThJC, De Rijke YB, and Kruijt JK (1991) Different fate in vivo of oxidatively modified low-density lipoprotein in rats. J Biol Chem 266:2282-2289.
32. Van Berkel ThJC, Kruijt JK, Spanjer HH, Nagelkerke JF, Harkes L, and Kempen HJM (1985) The effect of a water-soluble Tris-galactoside terminated cholesterol derivative on the fate of low-density lipoproteins and liposomes. J Biol Chem 260:2694-2699.
33. 2+ and trifluoperazine on the processing of human acetylated low-density-lipoprotein by non-parenchymal liver cells. FEBS Lett 132:61-66.
34. Yabukov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko LV, and Vlassov VV (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors. Proc Natl Acad Sci USA 86:6454-6458.
35. Zendegui JG, Vasquez KM, Tinsley JH, Kessler DJ, and Hogan ME (1992) In vivo stability and kinetics of absorption and disposition of 3′ phosphopropyl amine oligonucleotides. Nucleic Acids Res 20:307-314.
36. Zhao Q, Matson S, Herrera CJ, Fisher E, Yu H, and Krieg AM (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev 3:161-171.
37. Zhao Q, Waldschmidt T, Fisher E, Herrera CJ, and Krieg AM (1994) Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors. Blood 84:3660-3666.